22-20982391-CGGGGG-CGGGGGG
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PS3_SupportingPVS1PM3
This summary comes from the ClinGen Evidence Repository: The c.27dup (p.Gln10fs) variant in LZTR1 is a frameshift variant predicted to cause a premature stop codon 24 amino acids downstream in biologically-relevant-exon 1 (of 21) and is predicted to lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). The highest population minor allele frequency in gnomAD v2.1.1 is 0.0001139 (4/13466 alleles) in the East Asian population (PM2_Supporting, BS1, and BA1 are not met). This variant has been detected in 1 individual with RASopathy. They were compound heterozygous for the variant and a pathogenic or likely pathogenic variant and which was confirmed in trans by family testing (c.1943-256C>T (p.T648fs*36), 1 PM3 point, PMID:32623905) (PM3). ERK activation assay in patient-specific cardiomyocytes showed significantly increased levels of phosphorylated ERK supporting the abnormal impact due to loss of LZTR1 function (PMID:32623905)(PS3_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive RASopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: PVS1, PM3, PS3_Supporting. (ClinGen RASopathy VCEP specifications version 1.3; 12/3/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA10118264/MONDO:0021060/094
Frequency
Consequence
NM_006767.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- LZTR1-related schwannomatosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Noonan syndrome 10Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- schwannomatosisInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Noonan syndromeInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 2Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
- breast cancerInheritance: AD Classification: MODERATE Submitted by: G2P
- Costello syndromeInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome with multiple lentiginesInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- cardiofaciocutaneous syndromeInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome-like disorder with loose anagen hairInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006767.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LZTR1 | MANE Select | c.27dupG | p.Gln10AlafsTer24 | frameshift | Exon 1 of 21 | ENSP00000496779.1 | Q8N653 | ||
| LZTR1 | c.27dupG | p.Gln10AlafsTer24 | frameshift | Exon 1 of 21 | ENSP00000558088.1 | ||||
| LZTR1 | c.27dupG | p.Gln10AlafsTer24 | frameshift | Exon 1 of 21 | ENSP00000558091.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152160Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000100 AC: 16AN: 159396 AF XY: 0.0000817 show subpopulations
GnomAD4 exome AF: 0.0000669 AC: 94AN: 1405972Hom.: 0 Cov.: 32 AF XY: 0.0000792 AC XY: 55AN XY: 694278 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at